Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference87 articles.
1. American College of Rheumatology. ACR manual on contrast media: version 10.3. 2017. https://www.acr.org . Accessed 29 Mar 2018.
2. Grobner T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transpl. 2006;21(4):1104–8.
3. European Medicines Agency. Gadolinium-containing contrast agents and nephrogenic systemic fibrosis: long-term consequences of retention in human skin and bone. 2010. http://www.ema.europa.eu/ . Accessed 29 Mar 2018.
4. US FDA. New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. 2015. http://www.fda.gov . Accessed 29 Mar 2018.
5. Scott LJ. Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children. Clin Drug Investig. 2013;33(4):303–14.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献